| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 18, 2012 | Cebix Raises $30.9M in Series B Financing | Cebix, Inc., a La Jolla, California-based biopharmaceutical company developing treatments for complications of diabetes, has raised $30.9m in Series B financing.
Backers include existing investors InterWest, Sofinnova Ventures and Thomas, M... |
| Sep 19, 2012 | Acid reflux treatment company Torax Medical raises $30M in series D | Location: Shoreview, Minnesota.
Solution/product: LINX Reflux Management System uses a small, flexible band of interlinked titanium beads wrapped around magnetic cores that is laparoscopically implanted around the esophageal sphincter. The ... |
| May 22, 2012 | Spinal disc developer AxioMed ups series D to $20 million | AxioMed has been selling the lumbar disc in Germany, Switzerland and the United Kingdom.
Now, AxioMed turns its attention toward obtaining U.S. regulatory approval for its disc replacement devices. The company is conducting a pivotal clinic... |
| Apr 13, 2012 | Tioga Pharmaceuticals Closes $10M Series B Equity Financing | Tioga Pharmaceuticals, Inc., a San Diego, CA-based pharmaceutical company focused on developing novel treatments for gastrointestinal diseases, has closed a $10m Series B equity financing.
The round was led by new investor Thomas, McNerney ... |
| Dec 2, 2011 | InnoPharma Closes $15M Series A Financing | InnoPharma, Inc., a Piscataway, NJ-based developer of sterile generic and specialty pharmaceutical products, has completed a $15m Series A round of private financing.
The round was led by Thomas, McNerney & Partners.
The company intends... |
| Mar 1, 2011 | AxioMed Spine gets $500K state loan to help launch new product | The loan was recommended by a group associated with the Ohio Department of Development and is pending approval from the State Controlling Board.
AxioMed hopes to obtain European regulatory clearance, called the CE Mark, to commercialize its... |
| Jan 10, 2011 | Minnesota drug developer CNS Therapeutics raises $3 million | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| Jul 22, 2010 | AxioMed pulls in $14.5 million to fund U.S. spinal disc study | By Mary Vanac
AxioMed Spine Corp. raised $14.5 million in Series D funding to help the company finish enrolling patients for a pivotal U.S. clinical study of its lumbar disc replacement and earn CE Mark approval for its cervical disc in Eur... |
| Jul 22, 2010 | AxioMed Spine raises $14.5M for U.S. spinal disc study, EU launch | “We are fortunate to have supportive, high-caliber investors and the opportunity to add new investors to form a consortium with the ability to fund our product development programs,” Patrick McBrayer, the company’s president and CEO, said i... |
| Apr 7, 2010 | Torax Medical wins CE Mark for GERD device | By Brandon Glenn
Torax Medical Inc. won CE Mark approval in the European Union for an implantable device that treats patients suffering from acid-reflux disease.
The company’s Linx device is intended for patients with gastro-esophageal refl... |
| Apr 7, 2010 | Torax Medical gets European OK for acid reflux disease device | The device has not yet been cleared for U.S. sales. In September, Torax completed patient enrollment in a “pivotal” clinical trial that could be the springboard for approval by the Food and Drug Administration, according to Mark Stultz, sen... |
| Mar 22, 2010 | Rotation Medical spins up $4 million | By Brandon Glenn
Mysterious Minnesota biotech firm Rotation Medical Inc. raised nearly $3.9 million from an equity sale, according to a regulatory filing.
That brings the company’s total funding to $9 million after adding the new investment... |
| Mar 22, 2010 | Under-the-radar Rotation Medical grabs $3.9M equity investment | Rotation was founded by Thomas Hektner, a co-founder of StarFire Medical, a manufacturer of implantable devices for neurovascular disease that was acquired in 2008 by Palo Alto, Calif.-based Nfocus Neuromedical. Hektner didn’t immediately r... |
| Dec 1, 2009 | AxioMed Spine Corp. raises $6.4 million to continue developing spinal disc replacements | In May, the company won the CE Marking, which enables it to sell its disc replacements in Europe. At that time, AxioMed planned to introduce its lumbar spine disc replacement to the 27 European Union countries. It has introduced Freedom ... |
| Nov 12, 2009 | Isis Spinoff Altair Therapeutics Closes $17M Venture Round For Asthma Drug | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
[Corrected: 7:26 am Pacific, 11/12/09] San Diego-based Altair Therapeutics, a company developing inhalable drugs to block inflammatory proteins involved in asthma and other re... |
| Sep 10, 2009 | Minnesota’s Denali Medical raises $2 million | Denali’s board members include Michael DeMane, the former chief operating officer at Medtronic who in April joined the venture firm Thomas, McNerney & Partners as a senior advisor. The company previously raised $3 million in 2007, accor... |
| Aug 27, 2009 | Minnesota’s CNS Therapeutics raises $7 million | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R... |
| Aug 17, 2009 | M2 Group scores $6M for devices to treat diabetes | M2 Group Holdings, maker of disposable medical devices used to deliver medication for Type 1 diabetes, has raised $6 million of an anticipated $10 million round of equity, according to regulatory filings. Based in Sunnyvale, Calif., the com... |
| May 12, 2009 | AxioMed Spine Corp. earns coveted CE Marking to sell disc replacement in Europe | AxioMed on Tuesday said it has received Europe’s CE Marking — much like Food and Drug Administration market clearance in the United States. The company plans in the fall to introduce its lower-spine disc replacement, which uses a rubberize... |
| Mar 27, 2009 | Minnesota atrial fibrillation company Atritech raises $30 million | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| Under-the-radar Rotation Medical grabs $3.9M equity investment | Mysterious Minnesota biotech firm Rotation Medical Inc. has recently raised nearly $3.9 million in equity, according to a Securities and Exchange Commission filing.
That brings the company’s total funding to $9 million after adding the new ... |
| AxioMed Spine gets $500K state loan to help launch new product | A $500,000 loan from the state of Ohio will help AxioMed Spine manufacture and launch the company’s second product, an artificial cervical spine disc.
The company will use the loan to purchase machinery and equipment to manufacture the disc... |
| Minnesota drug developer CNS Therapeutics raises $3 million | On the heels of FDA approval of its new anti-spasticity drug Gablofen, CNS Therapeutics has raised $3 million in equity, according to documents filed with the Securities and Exchange Commission.
Gablofen (baclofen) is administered to the ce... |
| Torax Medical gets European OK for acid reflux disease device | Torax Medical Inc. has received regulatory approval from the European Union to sell an implantable device that treats patients suffering from acid reflux disease.
The company’s Linx device is intended for patients with gastroesophageal refl... |
| Minnesota’s CNS Therapeutics raises $7 million | WOODBURY, Minnesota — The early-stage pharmaceutical company CNS Therapeutics has raised $7 million, according to a filing with the Securities and Exchange Commission.
Not much is known about the 2-year-old company and CNS President John Fo... |
| Spinal disc developer AxioMed ups series D to $20 million | Fresh off receiving the CE Mark for its cervical spinal disc replacement device, AxioMed Spine has added $5 million to its series D round of investment.
The latest funding tranche brings Cleveland-area AxioMed’s series D round to $20 millio... |
| Acid reflux treatment company Torax Medical raises $30M in series D | Acid reflux treatment company Torax Medical announced Wednesday that it has raised $30 million in a series D round. The company makes an implant that uses magnetized titanium beads to prevent stomach acid from making its way into the esopha... |
| Entrepreneurs: VCs want to see (now more than ever) that you’re a good money manager | A financial investor, two venture capitalists and a corporate venture investor had different perspectives but all agreed on one thing at the MidAmerica Healthcare Venture Forum on Tuesday – the importance of capital efficiency in companies ... |
| Minnesota atrial fibrillation company Atritech raises $30 million | PLYMOUTH, Minnesota — A new $30 million investment will help the atrial fibrillation device-maker Atritech complete a U.S. Food and Drug Administration review and launch its product in Europe, according to a press release.
Atritech’s produc... |
| AxioMed Spine Corp. earns coveted CE Marking to sell disc replacement in Europe | Updated 8:38 p.m.
GARFIELD HEIGHTS, Ohio – This fall, AxioMed Spine Corp. in suburban Cleveland could start selling for the first time its spinal disc replacement after winning regulatory approval in Europe.
AxioMed on Tuesday said it ha... |
| Minnesota’s Denali Medical raises $2 million | PLYMOUTH, Minnesota — Biotech Denali Medical has raised $2 million, according to a filing with the Securities and Exchange Commission.
The 3-year-old business was started by Thomas Hektner. Hektner is the co-founder of StarFire Medical, a m... |
| AxioMed Spine Corp. raises $6.4 million to continue developing spinal disc replacements | GARFIELD HEIGHTS, Ohio — AxioMed Spine Corp. has completed the first part of its third financing round, raising $6.4 million from “leading venture capital firms,” which were not named.
The company that is developing next-generation spi... |
| AxioMed Spine raises $14.5M for U.S. spinal disc study, EU launch | AxioMed Spine Corp. has raised $14.5 million in Series D funding to help the Garfield Heights, Ohio company finish enrolling patients for a pivotal U.S. clinical study of its lumbar disc replacement, as well as earn CE Mark approval for its... |